摘要 |
The present invention is directed to a class of phenoxy-heterocyclic compounds of the formula I: <CHEM> in which R1 is represented by hydrogen, halogen, alkyl, alkoxy, OH, CF3, CN, methylenedioxy, ethylenedioxy, methylene, 2,3-benzo, 3,4-benzo, alkylthio, alkylsulfonyl, alkylsulfinyl, cycloalkyl, cycloalkoxy or cycloalkylthio; R2 is represented by halogen, alkyl, alkoxy, OH, CF3, CN, alkylthio, alkylsulfinyl, cycloalkyl, cycloalkoxy or cycloalkylthio; R3 is represented by hydrogen, halogen, alkyl, alkoxy, OH, CF3, CN, methylenedioxy, ethylenedioxy, methylene, 2,3-benzo, 3,4-benzo, 4,5-benzo, 5,6-benzo, alkylthio, alkylsulfonyl, alkylsulfinyl, cycloalkyl, cycloalkoxy or cycloalkylthio; m is represented by the integer 1 or 2; p is represented by an integer from 0-4; and the pharmaceutically acceptable addition salts thereof, and to their use as anti-depressants, anxiolytics and anti-hypertensive agents. |